Regulation is a market driver for the analytical technologies in the oil and gas industry. In August, the US EPA introduced a proposed rule on emission standards for methane and other volatile organic compounds in the oil and natural gas sector (see IBO 8/31/15). Leaks, or fugitive emissions, are a major source of emissions in […]
The June 2015 BP Statistical Review of World Energy reports that in 2014, oil was the most widely consumed source of energy globally, at 33% of worldwide energy consumption. Natural gas accounted for 24%. Although a reduction in oil exploration has accompanied the drop in oil prices starting in the second half of 2014, the […]
Clinical and Agbio Markets Boost Affymetrix Q2 Sales Affymetrix second quarter sales grew 4.1%, 7.9% excluding currency, to $89.0 million. Organic growth was driven by agbio and clinical sales, which climbed 24% and roughly 20%, respectively. Overall, consumables and instrument sales grew 4.8% and 16.8%, to account for 86% and 4% of revenues, respectively. Service […]
The second of IBO’s biannual features on new labs highlights facilities from the academic, government and industrial sectors, spanning a variety of disciplines. The table on page 6 lists some of the largest planned academic lab buildings as well as facilities for drug development. Also featured in this article are labs for agriculture, disease and […]
Tremendous progress has been made in using multiple reaction monitoring MS (MRM-MS) for verification of clinical biomarkers, for which it is widely used and accepted. Targeted proteomics, in which a subset of candidate biomarkers are detected and measured, using MRM-MS enables multiplex, high-throughput quantification from a few up to hundreds of proteins per sample, reducing […]
Agilent Lowers Outlook Given currency and the discontinued NMR business (see IBO 3/31/15), which reduced sales growth by 7% and 1%, respectively, Agilent Technologies fiscal third quarter sales ending July 31 grew 0.5% to $1,014 million (see page 12). Despite the modest growth, sales were above analysts’ expectations. Core sales, which exclude the NMR business, […]
The devaluation of China’s yuan sparked an extensive sell-off in the global equity markets in August. The S&P 500 and NASDAQ contracted 9% or more on three consecutive trading days beginning August 20. Despite strong surges on August 26, the Dow, S&P 500 and NASDAQ fell 6.6%, 6.3% and 6.9% for the month, respectively. The […]
Calendar year second quarter organic growth continued at a strong pace for major US publicly held instrument and laboratory product companies. However, currency headwinds, as well as weakness in industrial markets and Japan expunged organic growth. Currency reduced gains by about 7%, resulting in roughly flat second quarter average sales growth. Pharmaceutical and biotechnology markets […]
The US Bureau of Economic Analysis (BEA) released this month the latest figures for US companies’ R&D domestic spending and R&D spending by foreign-owned affiliates. The report shows dramatic shifts in annual R&D spending by both segments in recent years among industries that are major purchasers of analytical instruments. The data provide quantitative information on […]
Slow Growth for Bruker Despite higher-than-expected sales and sequential growth, Bruker’s Scientific Instruments (BSI) second quarter sales grew just 0.6% to $366.2 million to account for 92% of revenues (see page 12). Bruker BioSpin sales fell in the mid-single digits due to lower demand in Preclinical Imaging, which accounts for 20% of Group sales. The […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
